435 related articles for article (PubMed ID: 17253556)
1. Chemoimmunotherapy versus chemotherapy for metastatic malignant melanoma.
Sasse AD; Sasse EC; Clark LG; Ulloa L; Clark OA
Cochrane Database Syst Rev; 2007 Jan; (1):CD005413. PubMed ID: 17253556
[TBL] [Abstract][Full Text] [Related]
2. WITHDRAWN: Chemoimmunotherapy versus chemotherapy for metastatic malignant melanoma.
Sasse AD; Sasse EC; Clark LG; Clark OAC
Cochrane Database Syst Rev; 2018 Feb; 2(2):CD005413. PubMed ID: 29409139
[TBL] [Abstract][Full Text] [Related]
3. Systemic treatments for metastatic cutaneous melanoma.
Pasquali S; Hadjinicolaou AV; Chiarion Sileni V; Rossi CR; Mocellin S
Cochrane Database Syst Rev; 2018 Feb; 2(2):CD011123. PubMed ID: 29405038
[TBL] [Abstract][Full Text] [Related]
4. Interferon alpha for the adjuvant treatment of cutaneous melanoma.
Mocellin S; Lens MB; Pasquali S; Pilati P; Chiarion Sileni V
Cochrane Database Syst Rev; 2013 Jun; 2013(6):CD008955. PubMed ID: 23775773
[TBL] [Abstract][Full Text] [Related]
5. Combined chemoimmunotherapy in metastatic melanoma--is there a need for the double?
Schrader AJ
Anticancer Drugs; 2000 Mar; 11(3):143-8. PubMed ID: 10831272
[TBL] [Abstract][Full Text] [Related]
6. Systemic treatments for metastatic cutaneous melanoma.
Crosby T; Fish R; Coles B; Mason MD
Cochrane Database Syst Rev; 2000; (2):CD001215. PubMed ID: 10796759
[TBL] [Abstract][Full Text] [Related]
7. Chemotherapy and chemoimmunotherapy for metastatic malignant melanoma: review and recent advances.
Khayat D; Coeffic D
Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():238-47. PubMed ID: 10895160
[No Abstract] [Full Text] [Related]
8. High-dose chemotherapy followed by autologous stem cell transplantation for patients with relapsed/refractory Hodgkin lymphoma.
Rancea M; Monsef I; von Tresckow B; Engert A; Skoetz N
Cochrane Database Syst Rev; 2013 Jun; (6):CD009411. PubMed ID: 23784872
[TBL] [Abstract][Full Text] [Related]
9. Chemoimmunotherapy with dacarbazine, cisplatin, interferon-alpha2b and interleukin-2 versus two cycles of dacarbazine followed by chemoimmunotherapy in patients with metastatic melanoma: a randomised phase II study of the European Organization for Research and Treatment of Cancer Melanoma Group.
Punt CJ; Suciu S; Gore MA; Koller J; Kruit WH; Thomas J; Patel P; Lienard D; Eggermont AM; Keilholz U
Eur J Cancer; 2006 Nov; 42(17):2991-5. PubMed ID: 17023156
[TBL] [Abstract][Full Text] [Related]
10. WITHDRAWN: Systemic treatments for metastatic cutaneous melanoma.
Crosby T; Fish R; Coles B; Mason M
Cochrane Database Syst Rev; 2018 Feb; 2(2):CD001215. PubMed ID: 29411867
[TBL] [Abstract][Full Text] [Related]
11. [Therapy of malignant melanoma at the stage of distant metastasis].
Garbe C; Eigentler TK
Hautarzt; 2004 Feb; 55(2):195-213. PubMed ID: 15043023
[TBL] [Abstract][Full Text] [Related]
12. Pelvic floor muscle training added to another active treatment versus the same active treatment alone for urinary incontinence in women.
Ayeleke RO; Hay-Smith EJ; Omar MI
Cochrane Database Syst Rev; 2013 Nov; (11):CD010551. PubMed ID: 24259154
[TBL] [Abstract][Full Text] [Related]
13. High-dose chemotherapy and autologous haematopoietic stem cell rescue for children with high-risk neuroblastoma.
Yalçin B; Kremer LC; Caron HN; van Dalen EC
Cochrane Database Syst Rev; 2013 Aug; (8):CD006301. PubMed ID: 23970444
[TBL] [Abstract][Full Text] [Related]
14. Single-agent DTIC versus combination chemotherapy with or without immunotherapy in metastatic melanoma: a meta-analysis of 3273 patients from 20 randomized trials.
Huncharek M; Caubet JF; McGarry R
Melanoma Res; 2001 Feb; 11(1):75-81. PubMed ID: 11254118
[TBL] [Abstract][Full Text] [Related]
15. Interventions for the treatment of oral and oropharyngeal cancers: surgical treatment.
Oliver RJ; Clarkson JE; Conway DI; Glenny A; Macluskey M; Pavitt S; Sloan P; ; Worthington HV
Cochrane Database Syst Rev; 2007 Oct; (4):CD006205. PubMed ID: 17943894
[TBL] [Abstract][Full Text] [Related]
16. High-dose therapy with autologous stem cell transplantation versus chemotherapy or immuno-chemotherapy for follicular lymphoma in adults.
Schaaf M; Reiser M; Borchmann P; Engert A; Skoetz N
Cochrane Database Syst Rev; 2012 Jan; 1():CD007678. PubMed ID: 22258971
[TBL] [Abstract][Full Text] [Related]
17. Immunotherapy for advanced renal cell cancer.
Coppin C; Porzsolt F; Kumpf J; Coldman A; Wilt T
Cochrane Database Syst Rev; 2000; (3):CD001425. PubMed ID: 10908496
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-2-based immunotherapy and chemoimmunotherapy in metastatic melanoma.
Keilholz U; Scheibenbogen C; Brossart P; Möhler T; Tilgen W; Hunstein W
Recent Results Cancer Res; 1995; 139():383-90. PubMed ID: 7597305
[TBL] [Abstract][Full Text] [Related]
19. The majority of patients with metastatic melanoma are not represented in pivotal phase III immunotherapy trials.
Donia M; Kimper-Karl ML; Høyer KL; Bastholt L; Schmidt H; Svane IM
Eur J Cancer; 2017 Mar; 74():89-95. PubMed ID: 28335891
[TBL] [Abstract][Full Text] [Related]
20. Treatment of metastatic malignant melanoma.
Atallah E; Flaherty L
Curr Treat Options Oncol; 2005 May; 6(3):185-93. PubMed ID: 15869730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
